{"id":"https://openalex.org/W25318626","doi":null,"title":"Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.","display_name":"Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W25318626","mag":"25318626","pmid":"https://pubmed.ncbi.nlm.nih.gov/12082261"},"language":"en","primary_location":{"id":"pmid:12082261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12082261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical hemorheology and microcirculation","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055925178","display_name":"Alexei V. Muravyov","orcid":"https://orcid.org/0000-0002-5502-9164","observed_orcids":["https://orcid.org/0000-0002-5502-9164"]},"institutions":[{"id":"https://openalex.org/I198371094","display_name":"Yaroslavl State University","ror":"https://ror.org/044s2fj67","country_code":"RU","type":"education","lineage":["https://openalex.org/I198371094"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Alexei V Muravyov","raw_affiliation_strings":["Department of Medicine and Biology, University of Yaroslavl, 150000, Yaroslavl, Russia. anton@yspu.yar.ru"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine and Biology, University of Yaroslavl, 150000, Yaroslavl, Russia. anton@yspu.yar.ru","institution_ids":["https://openalex.org/I198371094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019403591","display_name":"Herbert J. Meiselman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert J Meiselman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079483041","display_name":"Vladimir V Yakusevich","orcid":"https://orcid.org/0000-0001-6035-9187","observed_orcids":["https://orcid.org/0000-0001-6035-9187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vladimir V Yakusevich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044967477","display_name":"Adrei V Zamishlayev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adrei V Zamishlayev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1622,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.48677344,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"26","issue":"2","first_page":"125","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11379","display_name":"Rheology and Fluid Dynamics Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1507","display_name":"Fluid Flow and Transfer Processes"},"field":{"id":"https://openalex.org/fields/15","display_name":"Chemical Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hemorheology","display_name":"hemorheology","score":0.875},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.9079999923706055},{"id":"https://openalex.org/keywords/essential-hypertension","display_name":"essential hypertension","score":0.9089999794960022},{"id":"https://openalex.org/keywords/women","display_name":"women","score":0.5270000100135803},{"id":"https://openalex.org/keywords/blood-viscosity","display_name":"blood viscosity","score":0.9639999866485596},{"id":"https://openalex.org/keywords/plasma-viscosity","display_name":"plasma viscosity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.6970000267028809},{"id":"https://openalex.org/keywords/red-blood-cell-aggregation","display_name":"erythrocyte aggregation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/hematocrit","display_name":"hematocrit","score":0.878000020980835},{"id":"https://openalex.org/keywords/spirapril","display_name":"spirapril","score":0.8330000042915344},{"id":"https://openalex.org/keywords/isradipine","display_name":"isradipine","score":0.9909999966621399},{"id":"https://openalex.org/keywords/talinolol","display_name":"talinolol","score":0.8859999775886536},{"id":"https://openalex.org/keywords/indapamide","display_name":"indapamide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.5569999814033508},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9800000190734863},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8999999761581421},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.8299999833106995},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C2780959883","wikidata":"https://www.wikidata.org/wiki/Q111146","display_name":"Hematocrit","level":2,"score":0.8427435159683228},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7207977771759033},{"id":"https://openalex.org/C2777748223","wikidata":"https://www.wikidata.org/wiki/Q1078392","display_name":"Indapamide","level":3,"score":0.7170325517654419},{"id":"https://openalex.org/C2994203641","wikidata":"https://www.wikidata.org/wiki/Q5712543","display_name":"Blood viscosity","level":2,"score":0.671301007270813},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.6484850645065308},{"id":"https://openalex.org/C2779918671","wikidata":"https://www.wikidata.org/wiki/Q200656","display_name":"Diuretic","level":2,"score":0.6390781402587891},{"id":"https://openalex.org/C78520924","wikidata":"https://www.wikidata.org/wiki/Q5712543","display_name":"Hemorheology","level":2,"score":0.5725967288017273},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5586094260215759},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.468315452337265},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.4486706554889679},{"id":"https://openalex.org/C2780192228","wikidata":"https://www.wikidata.org/wiki/Q575890","display_name":"Antihypertensive drug","level":3,"score":0.44628143310546875},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.440717488527298},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.3571929931640625}],"mesh":[{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001809","descriptor_name":"Blood Viscosity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001809","descriptor_name":"Blood Viscosity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004656","descriptor_name":"Enalapril","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004656","descriptor_name":"Enalapril","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005340","descriptor_name":"Fibrinogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006400","descriptor_name":"Hematocrit","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D007190","descriptor_name":"Indapamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017275","descriptor_name":"Isradipine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018056","descriptor_name":"Hemorheology","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12082261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12082261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical hemorheology and microcirculation","raw_type":"Clinical Trial"},{"id":"mag:25318626","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12082261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W67013428","https://openalex.org/W587382156","https://openalex.org/W925945020","https://openalex.org/W972718834","https://openalex.org/W1026514116","https://openalex.org/W1617739318","https://openalex.org/W1677575331","https://openalex.org/W1757865938","https://openalex.org/W1971675341","https://openalex.org/W1975186038","https://openalex.org/W1978039741","https://openalex.org/W1993507521","https://openalex.org/W2010546098","https://openalex.org/W2019908428","https://openalex.org/W2023018378","https://openalex.org/W2028701596","https://openalex.org/W2043284502","https://openalex.org/W2064883554","https://openalex.org/W2065727122","https://openalex.org/W2075228082","https://openalex.org/W2075913195","https://openalex.org/W2084266834","https://openalex.org/W2089271753","https://openalex.org/W2143347316","https://openalex.org/W2161054601","https://openalex.org/W2399800668","https://openalex.org/W2406924510","https://openalex.org/W2412724851","https://openalex.org/W2416251780","https://openalex.org/W2418516071","https://openalex.org/W2561950855"],"related_works":["https://openalex.org/W925945020","https://openalex.org/W2565908809","https://openalex.org/W2363730796","https://openalex.org/W7099214893","https://openalex.org/W2033803177","https://openalex.org/W2169211183","https://openalex.org/W17607991","https://openalex.org/W2437788056","https://openalex.org/W116230632","https://openalex.org/W2080885892"],"abstract_inverted_index":{"This":[0],"study":[1],"was":[2,180],"designed":[3],"to":[4,91],"examine":[5],"changes":[6],"of":[7,49,62,119,139,190,201],"hemorheological":[8,99,137,215],"parameters":[9,161],"in":[10,128,155,165,175,213],"essential":[11],"arterial":[12],"hypertension":[13],"subjects":[14,22,53],"following":[15,93],"antihypertensive":[16,140,191],"drug":[17,94,141,192],"therapy.":[18],"Eighty":[19],"two":[20,28],"female":[21],"were":[23,54,152,162],"enrolled,":[24],"and":[25,51,92,105,113,132,148,171,204],"sub-divided":[26],"into":[27],"groups":[29,158],"based":[30],"upon":[31],"their":[32],"high":[33,104],"shear":[34,107],"whole":[35,108,149],"blood":[36,109,126,150],"viscosity":[37,151],"being":[38],"lower":[39],"(L)":[40],"or":[41],"higher":[42],"(H)":[43],"than":[44],"normal":[45],"controls.":[46],"Equal":[47],"numbers":[48],"L":[50,131,157],"H":[52,133,167],"then":[55],"treated":[56],"for":[57,96,206],"four":[58,63,121],"weeks":[59],"with":[60,117],"one":[61],"agents:":[64],"angiotensin-converting":[65],"enzyme":[66],"inhibitor":[67],"(ACE-inhibitor,":[68],"Spirapril":[69],"-":[70,76,81,86],"6":[71],"mg/day);":[72,78,83],"calcium":[73],"antagonist":[74],"(Isradipin":[75],"5":[77],"beta-1-blocker":[79],"(Talinolol":[80],"100":[82],"diuretic":[84],"(Indapamide":[85],"1.5":[87],"mg/day).":[88],"Both":[89],"prior":[90],"treatment":[95],"six":[97],"weeks,":[98],"measurements":[100],"included":[101],"plasma":[102,147],"viscosity;":[103],"low":[106],"viscosity,":[110],"hematocrit,":[111],"fibrinogen":[112],"RBC":[114,172],"aggregation.":[115],"Treatment":[116],"each":[118],"the":[120,130,136,156,166,187,197,202],"drugs":[122],"significantly":[123,153,163],"(p<0.05)":[124],"reduced":[125],"pressure":[127],"both":[129,176],"groups.":[134,168],"However,":[135],"effects":[138,189],"therapy":[142,193,210],"differed":[143],"markedly":[144],"between":[145],"groups:":[146],"elevated":[154],"whereas":[159,178],"these":[160],"decreased":[164,174],"Fibrinogen":[169],"levels":[170],"aggregation":[173],"groups,":[177],"hematocrit":[179],"unaffected.":[181],"These":[182],"results":[183],"thus":[184],"suggest":[185],"that":[186,205],"rheologic":[188],"depend":[194],"strongly":[195],"on":[196],"initial,":[198],"pre-treatment":[199],"status":[200],"subject,":[203],"some":[207],"subjects,":[208],"such":[209],"can":[211],"result":[212],"adverse":[214],"alterations.":[216]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}